Antibiotic therapy - Biotech, Pharma and Life Science Channel

20:33 EST 22nd December 2014 | BioPortfolio

PubMed Articles [10143 Associated PubMed Articles listed on BioPortfolio]

In-vitro Characterization and Evaluation of Apoptotic Potential of Bicistronic Plasmid Encoding HN Gene of Newcastle Disease Virus and Human TNF-α

The viral gene oncotherapy in combination with cytokines emerges as an exciting strategy for cancer therapy due to its minimal side effects and tumor specificity. HN is the surface protein of NDV whic...

Determination of tetracycline hydrochloride by terahertz spectroscopy with PLSR model.

Antibiotic residues in agricultural and food products are of great concern to legislatures and consumers. Reliable techniques for rapid and sensitive detection of these residues are necessary to ensur...

Laser desorption postionization mass spectrometry imaging of biological targets.

Laser desorption photoionization mass spectrometry (LDPI-MS) utilizes two separate light sources for desorption and photoionization of species from a solid surface. This technique has been applied to ...

Medication Overuse Headache.

Medication overuse headache (MOH) is a common and disabling headache disorder. It has a prevalence of about 1-2 % in the general population. The International Classification of Headache Disorders 3rd...

An Update and Review of the Treatment of Myoclonus.

Recent advances in medications and surgical therapy for neurological disorders may offer new therapeutic options for the treatment of myoclonus. Appropriate therapy for myoclonus depends on the etiolo...

The role of antisense oligonucleotide therapy in patients with familial hypercholesterolemia: risks, benefits, and management recommendations.

Antisense oligonucleotide therapy is a promising approach for the treatment of a broad variety of medical conditions. It functions at the cellular level by interfering with RNA function, often leading...

Hemodynamic Deterioration During Extracorporeal Membrane Oxygenation Weaning in a Patient With a Total Artificial Heart.

The Total Artificial Heart (Syncardia, Tucson, AZ) is approved for use as a bridge-to-transplant or destination therapy in patients who have irreversible end-stage biventricular heart failure. We pres...

Cerebral Perfusion Pressure Versus Intracranial Pressure-Driven Therapy on Outcomes.

Machine-Learning Techniques Applied to Antibacterial Drug Discovery.

The emergence of drug-resistant bacteria threatens to revert humanity back to the preantibiotic era. Even now, multidrug-resistant bacterial infections annually result in millions of hospital days, bi...

The Bacterial Type III Secretion System as a Target for Developing New Antibiotics.

Antibiotic resistance in pathogens requires new targets for developing novel antibacterials. The bacterial type III secretion system (T3SS) is an attractive target for developing antibacterials as it ...

News Articles [5912 Associated News Articles listed on BioPortfolio]

Catalent Contracted to Manufacture Valerion's Orphan Drug

The alliance will join forces to develop Valerion’s lead product candidates — for delivery of muscle-protein fusions, and treatment of multiple indications respectively, in the muscular dystrophy,...

Testosterone Lawsuits Move Forward in Federal Court, With Establishment of New Case Management Plan, Bernstein Liebhard LLP Reports

Order directs parties in federal testosterone treatment lawsuits to meet and confer regarding the selection of cases for certain bellwether trials. New York, New York (PRWEB) December 22, 2014 Testos...

High Doses of Vancomycin Fuel Risk of Kidney Damage in Children

Results of a small Johns Hopkins Children’s Center study show that hospitalized children given high-dose IV infusions of the antibiotic vancomycin to treat drug-resistant bacterial infections face a...

FDA Approves Cubist Antibiotic for Serious Infections

The Food and Drug Administration has approved a new medicine to fight complex infections in the abdomen and urinary tract, the fourth antibiotic the agency has approved since May.Zerbaxa treats seriou...

Viekira Pak™ approved for treatment of genotype 1 chronic hepatitis C, Diplomat to distribute

FLINT, Mich., Dec. 22, 2014 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation's largest independent specialty pharmacy, announced that it will stock Viekira Pak™ (ombita...

Risk for leukemia after treatment for early-stage breast cancer higher than reported

The risk of developing leukemia after radiation therapy or chemotherapy for early stage breast cancer remains very small, but it is twice as high as previously reported, according to results of a new ...

Relmada doses first subjects in d-Methadone trial

Relmada Therapeutics (OTCQB:RLMD) has dosed the first cohort of subjects in a pharmacokinetic and pharmacodynamic study with d-Methadone, its N-methyl-D-aspartate (NMDA) receptor antagonist for neurop...

Cubist boosts antibiotics market presence

Cubist has followed-up its successful European approval for a new antibiotic by winning an endorsement by the US FDA. The regulator gave the company’s new antibiotic, Zerbaxa (ceftolozane/tazobactam...

Hospital News: A Stepped-Up Focus On Antibiotic Resistance

In addition, Modern Healthcare reports on the debate over whether programs to encourage efficiency and prevent hospital readmissions are helping control health care costs.

Welcome to an Elekta R&D update at University Medical Center Utrecht

Regulatory News: Elekta welcomes investors, analysts and media to an update on its investments in R&D, with special attention to the Atlantic project: a mag...

Events [0 Results]

None

Companies [280 Associated Companies listed on BioPortfolio]

Hygea Holdings Corp.

Hygea is a diversified healthcare holding company led by a team of nationally recognized industry leaders with backgrounds in insurance, finance, medicine, and technology. The com...

Prima-Temp

Prima-Temp brings new, innovative approaches to many of today’s healthcare challenges through the application of 21st century thermometry. Prima-Temp’s continuous temper...

NovoCure

Novocure is a private Jersey Isle oncology company pioneering a novel therapy for solid tumors called TTFields. Novocure US operations are based in Portsmouth, NH and New York, NY...

Cell Therapy Catapult

The Cell Therapy Catapult is a centre of translational excellence for cell therapy and regenerative medicine. Its vision is for the UK to be a global leader in the development, de...

Select Medical Corporation

Co-founded by the father–and–son team of Rocco and Robert Ortenzio in 1996, Select Medical has become one of the nation's largest providers of specialized acute and post...

Eckert & Ziegler AG

Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700), with more than 700 employees, is one of the world’s largest providers of isotope technology for radiatio...

Dimension Therapeutics, Inc.

Dimension Therapeutics, Inc. is a gene therapy company focused on developing novel treatments for patients with hemophilia and rare diseases. Dimension has built a product develop...

BioMonde, LLC

Since 1994 BioMonde have manufactured and supplied Larval Therapy in Europe and the UK. BioMonde are the sole producers of ‘BioBag,’ which provides clinicians and patien...

The Vaccine & Gene Therapy Institute of Florida

Athletico Physical Therapy

Athletico Physical Therapy provides the highest quality orthopedic rehabilitation services to communities and organizations, with 88 locations throughout Illinois, Wisconsin and I...

Clinical Trials [1088 Associated Clinical Trials listed on BioPortfolio]

Multi-Beam Intensity-Modulated Radiation Therapy for Node-Positive Breast Cancer

This study is being performed to understand the safety of a new radiation treatment called "Multi-Beam Intensity Modulated Radiation Therapy" ( IMRT). Currently, the standard way of giving...

Laser Therapy for the Management of Radiation Dermatitis

Low Level Laser Therapy (LLLT) is a form of phototherapy which involves the application of light to injuries and lesions to promote tissue regeneration. It is a noninvasive treatment modal...

REPEAT Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Therapy in Combination With COPEGUS (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Who Did Not Respond to Previous PegIntron (Peginterferon Alfa-2b (12KD))/Ribavirin Combination Ther

This 4 arm study is designed for patients with CHC who have not responded to peg interferon alfa-2b (12KD)/ribavirin combination therapy. In these patients, the effects of lengthening the ...

Enhancing Delivery of Problem Solving Therapy Using SmartPhone Technology

This project will be the first to evaluate the Moving Forward app in VA. Identifying an effective treatment for anxiety and depression in primary care is imperative within VHA as they are ...

Minocycline Study in Non Small Cell Lung Cancer (NSCLC) Patients for Chemoradiation Therapy

The goal of this clinical research study is to learn if minocycline can reduce the side effects reported by patients with NSCLC who are receiving chemoradiation therapy. In this study, mi...

Radiation Therapy and Intratumoral Autologous Dendritic Cells in Soft Tissue Sarcomas (STS)

The purpose of this study is to determine if injection of the participant's our own immune related white blood cells (called dendritic cells) into their tumor will strengthen their immune ...

Project CLEAR - Changing Lives by Eradicating Antibiotic Resistance

This randomized controlled trial will compare strategies to reduce the risk of methicillin-resistant Staphylococcus aureus (MRSA) infection and re-hospitalization in MRSA carriers. This tr...

Comparative Study of Ertapenem Versus Another Antibiotic in the Treatment of Diabetic Foot Infections in Adults (0826-034)

This study will compare the efficacy, safety and tolerability of intravenous ertapenem versus another intravenous antibiotic in the treatment of moderate to severe diabetic foot infection...

Evaluation of Skin, Colonic, and Oral Microbiome and Effect of Time and Antibiotic Treatment on Organism Diversity at Each Site

Background: - Most studies of infectious agents have focused on specific microbes, such as human papillomaviruses and cervical cancer, and the hepatitis B and C virus and liver ca...

Cisplatin and Radiation Therapy With or Without Triapine in Treating Patients With Previously Untreated Stage IB-IVA Cervical Cancer or Stage II-IVA Vaginal Cancer

This randomized phase II trial studies how well cisplatin and radiation therapy with or without triapine work in treating patients with previously untreated stage IB-IVA cervical cancer or...

Medical and Biotech [MESH] Definitions

A beta-lactamase inhibitor with very weak antibacterial action. The compound prevents antibiotic destruction of beta-lactam antibiotics by inhibiting beta-lactamases, thus extending their spectrum activity. Combinations of sulbactam with beta-lactam antibiotics have been used successfully for the therapy of infections caused by organisms resistant to the antibiotic alone.

Preliminary cancer therapy (chemotherapy, radiation therapy, hormone/endocrine therapy, immunotherapy, hyperthermia, etc.) that precedes a necessary second modality of treatment.

The presence of fungi circulating in the blood. Opportunistic fungal sepsis is seen most often in immunosuppressed patients with severe neutropenia or in postoperative patients with intravenous catheters and usually follows prolonged antibiotic therapy.

A common inhabitant of the colon flora in human infants and sometimes in adults. It produces a toxin that causes pseudomembranous enterocolitis (ENTEROCOLITIS, PSEUDOMEMBRANOUS) in patients receiving antibiotic therapy.

A therapeutic approach, involving chemotherapy, radiation therapy, or surgery, after initial regimens have failed to lead to improvement in a patient's condition. Salvage therapy is most often used for neoplastic diseases.

Search BioPortfolio:
Loading
Advertisement
Advertisement
review and buy Antibiotic therapy market research data and corporate reports here

Channels Quicklinks